SCHEMBL4810370

SCHEMBL4810370

CCCCCCCCCCCCSCCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.67
PPARG P37231 7/20 0.67
PPARD Q03181 7/20 0.67
PPARA Q07869 7/20 0.67
HDAC11 Q96DB2 5/20 0.67
TSHR P16473 5/20 0.67
PTPN1 P18031 3/20 0.67
HSD17B10 Q99714 3/20 0.67
MAPT P10636 3/20 0.67
ALDH1A1 P00352 2/20 0.67
TLR2 O60603 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
FABP4 P15090 2/20 0.67
KMT2A Q03164 2/20 0.67
ALOX15 P16050 2/20 0.67
GMNN O75496 2/20 0.67
POLB P06746 2/20 0.67
CYP2C9 P11712 2/20 0.67
BLM P54132 2/20 0.67
SLC22A6 Q4U2R8 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8865695 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL6580219 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7584121 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7083600 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL8609722 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3728626 1.00 GPR84 (0.67) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL2229369 0.96 GPR84 (0.74) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL15593804 0.96 GPR84 (0.74) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7749100 0.96 GPR84 (0.74) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL7201642 0.96 GPR84 (0.74) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114045145-B Adhesive composition 尤尼吉可株式会社 2024-01-23 CN disclosed
CN-114045145-A Adhesive composition 尤尼吉可株式会社 2022-02-15 CN disclosed
CN-112969757-A Resin composition 尤尼吉可株式会社 2021-06-15 CN disclosed
US-7375135-B2 Fatty acid derivatives; preparation and uses thereof GENFIT (FR) 2008-05-20 US disclosed
US-20060252827-A1 Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof GENFIT (FR) 2006-11-09 US disclosed
EP-1285652-B1 Novel fatty acid analogues for the treatment of hypertension THIA MEDICA AS (NO) 2006-08-16 EP disclosed
EP-1284139-B1 Novel fatty acid analogues for the treatment of fatty liver THIA MEDICA AS (NO) 2006-08-02 EP disclosed
US-20060154984-A1 Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof GENFIT (FR) 2006-07-13 US disclosed
EP-1075260-B1 NOVEL FATTY ACID ANALOGUES FOR THE TREATMENT OF SECONDARY RESTENOSIS THIA MEDICA AS (NO) 2005-10-19 EP disclosed
US-20040192908-A1 Fatty acid compounds, preparation and uses thereof GENFIT (FR) 2004-09-30 US disclosed
EP-1075258-B1 NOVEL FATTY ANALOGUES FOR THE TREATMENT OF OBESITY THIA MEDICA AS (NO) 2003-08-20 EP disclosed
EP-1075259-B1 NOVEL FATTY ANALOGUES FOR THE TREATMENT OF DIABETES THIA MEDICA AS (NO) 2003-07-23 EP disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed
EP-0401193-B1 Rubber compositions having improved processability MONSANTO EUROPE SA (BE) 1996-09-18 EP disclosed
US-5023289-A Alkylthioalkanoic acid flow control agent MONSANTO EUROPE, S.A. (BE) 1991-06-11 US disclosed
EP-0401193-A1 Rubber compositions having improved processability MONSANTO EUROPE S.A./N.V. (BE) 1990-12-05 EP disclosed
US-4125516-A HEAT STABILIZER, ANTIOXIDANT, DISCOLORATION INHIBITON CIBA-GEIGY CORPORATION (US) 1978-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252827-A1 Therapeutic use of of acyglycerols and the nitrogen-and sulphur-containing analogues thereof SGMS2, SGMS1, AGK GPR84 622/4885PPARG 230/4885PPARD 797/4885
US-20040192908-A1 Fatty acid compounds, preparation and uses thereof FASN, FFAR1, PLIN5 GPR84 374/4885PPARG 16/4885PPARD 48/4885
US-20060154984-A1 Therapeutic use of acyl glycerols and the nitrogen- and sulphur- containing analogues thereof AGPAT5, HAGH, AGPAT2 GPR84 1091/4885PPARG 129/4885PPARD 400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.